VEGF Trap in Treating Patients With Metastatic Breast Cancer

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
National Cancer Institute (NCI)
Study ID
NCT00369655
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This phase II trial is studying how well VEGF Trap works in treating patients with metastatic breast cancer. VEGF Trap may stop the growth of tumor cells by blocking blood flow to the tumor

Key Dates

First listed
Aug 29, 2006
Start date
Jan 31, 2007
Status verified
Nov 2013
Primary completion
Mar 31, 2008
Completion
Jan 31, 2011

Study Design

Enrollment
21 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment (ziv-afibercept)
    Patients receive VEGF Trap IV over 1 hour on day 1. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.

Primary Outcome Measure

Proportion of Patients With Confirmed Tumor Response [ Time Frame: Up to 5 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
North Central Cancer Treatment GroupRochesterMinnesota55905-

Find similar trials in Rochester, MN

Nationwide
Breast cancer trialsOncology trialsBreast oncology trialsWomen's health trials
By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
North Central Cancer Treatment Group· Rochester, MN

Related Studies